Regulation of Compounding Pharmacies

Published Online: Tuesday, October 22, 2013
Follow Pharmacy_Times:
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses whether and how regulation of compounding pharmacies needs to change in the wake of the meningitis outbreak caused by tainted steroids produced by the New England Compounding Center.

Related Articles
With patients delivering homemade sweets to your pharmacy counter, how can you ensure that the turkey is the only one stuffed during the holiday season?
To provide further guidance on issues concerning drug compounding, the FDA today announced that experts in pharmacy, pharmaceutical compounding and manufacturing, medicine, and pharmaceutical regulation will comprise the Pharmacy Compounding Advisory Committee.
Although the proposed USP General Chapter <800> is not anticipated to take effect for at least the next 2 years, an expert panel described how pharmacists can start preparing for the new standards in handling hazardous drugs.
The key to encouraging patient proactivity at Burmans Pharmacy is to stress medication adherence, director of compounding Vince Canzanese, RPh, explains.
Latest Issues
$auto_registration$